... types of particles used in medicine, such as the viruses used in the human papillomavirus (HPV) vaccine and gene therapy. “The adaptation of this technology is just one of many excellent examples of how NIST ...
... rate of anaphylaxis in young women after human papillomavirus (HPV) vaccination was significantly higher – 5 to 20 fold – than that identified in comparable school ...
... 's decision to choose the vaccine Cervarix for the UK human papillomavirus (HPV) vaccination programme, every doctor I have spoken to has chosen Gardisal for their own ...
... 's Hospital Medical Center. The quadrivalent human papillomavirus (HPV) vaccine has been mired in controversy since it was approved in 2006. Texas placed itself ...
... PhysOrg.com) -- Injections of the human papillomavirus (HPV) vaccine appear to be no more painful than other shots that prevent disease, according to a new study ...
... values influence how risky they perceive the human papillomavirus (HPV) vaccine to be and thus, their views on whether or not the vaccine should be mandatory for elementary school ...
... percent of eligible adult women have had the human papillomavirus (HPV) vaccine; and only 36.1 percent of all adults were vaccinated against the seasonal flu ...
High-coverage human papillomavirus (HPV) vaccinations among adolescents and young women may result in a rapid reduction of genital ...
... overall potential benefits of human papillomavirus (HPV) vaccinations or frequent HPV screenings for women over the age of 41 are low, concludes ...
... overall potential benefits of human papillomavirus (HPV) vaccinations or frequent HPV screenings for women over the age of 41 are low, concludes ...
Nearly all U.S. states offer the human papillomavirus (HPV) vaccine to adolescent girls who have been arrested or detained, according to a new report from The Miriam Hospital ...
... three young women has received the human papillomavirus (HPV) vaccine to help prevent cervical cancer, according to a new report from researchers at Washington ...
... , few of the young women who are eligible for the human papillomavirus (HPV) vaccine take it, according to research presented at the Ninth Annual AACR Frontiers in Cancer ...
... and expected lower cost than the current commercial human papillomavirus (HPV) vaccine used throughout the world. HPV is the number one cause of cervical cancer, which is the second ...
... role in convincing them to receive the human papillomavirus (HPV) vaccine, new research suggests. A study found that college-aged women were more likely ...
